Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health | FMCG | Executive
         
Latest Jobs

Durham, Darlington, Teesside, York & Hull regions
17 May 2013 10:37



Scotland
17 May 2013 10:37



Nyon, Switzerland
11 April 2013 11:55


Exclusive vacancies may not be shown here, please contact Alex on +44 1494 818021 or alex@zenopa.com for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Alex Reynolds
Account Manager
alex@zenopa.com
+44 1494 818021

Testimonials
It has been an absolute pleasure dealing with Zenopa ever since I registered an interest in finding a new employment opportunity.
Bobby, 2012

Shire changes NASDAQ ticker

11 July 2012 11:40 in Pharmaceutical Company Financials


Shire has announced a change to the NASDAQ ticker symbol for its American depositary shares (ADS).

From the opening of trading today (July 11th), the symbol will be amended from 'SHPGY' to 'SHPG'.

In a statement, the biopharmaceutical company confirmed that each ADS will continue to represent three ordinary shares in Shire and the London Stock Exchange ticker symbol for the firm's ordinary shares will remain 'SHP'.

The announcement comes after Shire announced strong financial results for the first quarter of 2012, with revenues jumping by 21 percent to $1.17 billion (722.57 million pounds).

It reported earnings per ADS (American Depositary Share) of $1.48 in the three months to the end of March 2012.

Chief executive Angus Russell said the firm's performance during the quarter was boosted by the strength of its ADHD (attention deficit hyperactivity disorder) drugs Vyvanse and Intuniv, which both increased their market share.ADNFCR-8000103-ID-801405218-ADNFCR

Other news stories from 11/07/2012

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Adfero News Agency



   
© Copyright 2013 Zenopa Ltd